|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Sensei Biotherapeutics, Inc. (SNSE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
16 |
|
|
|
Total
Direct Shares :
|
13,645,194 |
|
|
Total
Indirect Shares :
|
3,988,051 |
| |
%
Held by Insiders:
|
44.61% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Colgan Erin |
|
2024-02-15 |
67,462 |
2022-02-15 |
0 |
| Van Der Horst Edward |
|
2024-02-15 |
56,070 |
|
0 |
| Celebi John |
|
2024-02-15 |
105,420 |
2022-02-15 |
0 |
| Cambrian Biopharma Inc |
|
2023-07-31 |
3,653,120 |
|
0 |
| Ricks Thomas G |
Director |
2023-07-10 |
8,932 |
2023-07-10 |
334,931 |
| English Jessie |
Director |
2023-07-10 |
8,932 |
2023-07-10 |
0 |
| Ringo William R |
Director |
2023-07-10 |
23,399 |
2022-03-08 |
0 |
| Humer Kristian |
Director |
2023-07-10 |
8,932 |
2023-07-10 |
0 |
| Holmen Bob |
Director |
2023-07-10 |
25,598 |
|
0 |
| Vojta Deneen |
Director |
2023-07-10 |
8,932 |
2023-07-10 |
0 |
| Broder Samuel |
Director |
2023-07-10 |
8,932 |
2023-07-10 |
0 |
| Gallagher Patrick Stephen |
Chief Business Officer |
2023-02-15 |
34,130 |
2023-02-15 |
0 |
| Peyer James |
|
2022-02-16 |
5,188,337 |
2023-07-31 |
3,653,120 |
| Pierce Robert Hamilton |
Chief R&D Officer |
2022-02-15 |
21,000 |
2021-08-11 |
0 |
| Samueli Susan |
10% Owner |
2021-02-08 |
4,425,998 |
|
0 |
| Presight Co-Invest Management, L.l.c. |
See Explanation of Responses |
|
0 |
2023-06-01 |
0 |
|
|
